GSK vs LDOS · P/E 13, $103.31B cap vs P/E 16, rev $8.96B
GlaxoSmithKline PLC ADR (GSK) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the GSK and LDOS stock pages for the full models.
Not investment advice.